Unexpected Acute Severe Anemia In a Jehova's Witness Patient After Peripheral Vascular Surgery: Treatment Challenges and Dilemmas

Number: 3 September 1, 2013
  • Ufuk Mungan
  • Levent Mavioğlu
  • Çağatay Ertan
  • Murat Dinçer
  • Mehmet Ali Özatik
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi Cover
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi
PDF Download
EN TR

Unexpected Acute Severe Anemia In a Jehova's Witness Patient After Peripheral Vascular Surgery: Treatment Challenges and Dilemmas

Abstract

The history of Jehovah’s Witnesses began more than a hundred years ago. Today the Watchtower Society has over 6 million active Jehovah’s Witnesses all around the world spreading its doctrines in 235 countries. Jehovah’s Witnesses refuse blood transfusions, which they consider a violation of God’s law even in “a life-or-death situation”. According to a report published in 2004, the total number of Jehovah’s Witnesses in our country whose population is 67 million and which consists of 32 communities, is 1784. In recent years, with technological developments and improvements in surgical experiences, surgical interventions especially cardiac are practised with a low risk to patients in societies who refuse blood transfusions such as Jehovah’s Witnesses. However, as in our case report, experiences and data about procedures that could be done in severe anemia which develops unexpectedly following peripheral vascular surgery are quite few. Therefore, in our case report, our experiences with our patient who was a Jehovah’s Witness with severe anemia following peripheral vascular surgery are mentioned

Keywords

References

  1. 1. Vaislic CD, Dalibon N, Ponzio O, Ba M, Jugan E, Lagneau F et al. Outcomes in cardiac surgery in 500 consecutive Jehovah’s Witness patients: 21 year Experience. J Cardiothorac Surg 2012;27:95. 2. Jordan SD, Alexander E. Bovine Hemoglobin: A Nontraditional Approach to the Management of Acute Anemia in a Jehovah’s Witness Patient With Autoimmune Hemolytic Anemia. J Pharm Pract 2012 Aug 6. [Epub ahead of print]
  2. 3. Donahue LL, Shapira I, Shander A, Kolitz J, Allen S, Greenburg G. Management of acute anemia in a Jehovah’s Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature. Transfusion 2010;50:1561-7. Epub 2010 Apr 23. Review.
  3. 4. Hemopure® [package insert]. South Africa: S.A. Biopure (PTY) LTD, 2001
  4. 5. Estep T, Bucci E, Farmer M, Greenburg G, Harrington J, Kim HW et al. Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working group Workshop, March 1, 2006. Transfusion 2008;776–82.
  5. 6. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 2008;299:2324–32.
  6. 7. Food and Drug Administration. 21CFR 56.104: Institutional review boards. Exemptions from IRB requirement. 2002
  7. 8. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055–60.
  8. 9. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988;727–9.

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Ufuk Mungan

Levent Mavioğlu

Çağatay Ertan

Murat Dinçer

Mehmet Ali Özatik

Publication Date

September 1, 2013

Submission Date

-

Acceptance Date

-

Published in Issue

Year 1970 Number: 3

IZ

https://izlik.org/JA33TL44WM

Cite

RIS / Bibtex
EndNote
Mungan U, Mavioğlu L, Ertan Ç, Dinçer M, Özatik MA (September 1, 2013) Yehova Şahidi Olan Hastada Vasküler Cerrahi Sonrası Beklenmedik Bir Şekilde Gelişen Ciddi Anemi: Tedavideki Zorluklar ve İkilemler. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 3 148–153.